PE20060382A1 - Derivados de 1,1,2,2-tetra(hetero)ariletano o 1,1,2-tri(hetero)cicliletano como inhibidores del canal de potasio - Google Patents
Derivados de 1,1,2,2-tetra(hetero)ariletano o 1,1,2-tri(hetero)cicliletano como inhibidores del canal de potasioInfo
- Publication number
- PE20060382A1 PE20060382A1 PE2005000858A PE2005000858A PE20060382A1 PE 20060382 A1 PE20060382 A1 PE 20060382A1 PE 2005000858 A PE2005000858 A PE 2005000858A PE 2005000858 A PE2005000858 A PE 2005000858A PE 20060382 A1 PE20060382 A1 PE 20060382A1
- Authority
- PE
- Peru
- Prior art keywords
- inhibitors
- ilethyl
- ring
- cyclylethane
- arylethane
- Prior art date
Links
- 102000004257 Potassium Channel Human genes 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 108020001213 potassium channel Proteins 0.000 title abstract 2
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- -1 4-FLUOROPHENYL Chemical class 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE A, B Y C SON CADA UNO ARILO Y ANILLO MONOCICLICO NO SATURADO DE 5, 6 MIEMBROS O UN ANILLO BICICLICO NO SATURADO DE 8-10 MIEMBROS CON 1-4 HETEROATOMOS DE N, O, S; D ES ARILO, ANILLO MONOCICLICO NO SATURADO DE 5, 6 MIEMBROS O UN ANILLO BICICLO NO SATURADO DE 8-10 MIEMBROS CON 1-4 HETEROATOMOS DE N, O, S; X E Y SON CADA UNO H, OH, O-(ALQUILO C1-C6), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: (R)-N-{6-[1-(4-FLUOROFENIL)-2,2-DIPIRIDIN-3-ILETIL]PIRIDIN-2-IL}METANOSULFONAMIDA; (S)-N-{6-[1-(6-METOXIPIRIDIN-2-IL)-2,2-DIPRIDIN-3-ILETIL]PIRIDIN-2-IL}METANOSULFONAMIDA; (S)-3-[1-(2-AMINOPIRIMIDIN-4-IL)-2,2-DIPIRIDIN-3-ILETIL]BENZONITRILO; ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON INHIBIDORES DE CANALES DE POTASIO (Kv1.5) UTILES EN EL TRATAMIENTO DE ARRITMIAS CARDIACAS Y SIMILARES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59218104P | 2004-07-29 | 2004-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20060382A1 true PE20060382A1 (es) | 2006-05-15 |
Family
ID=35613661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005000858A PE20060382A1 (es) | 2004-07-29 | 2005-07-22 | Derivados de 1,1,2,2-tetra(hetero)ariletano o 1,1,2-tri(hetero)cicliletano como inhibidores del canal de potasio |
Country Status (15)
| Country | Link |
|---|---|
| KR (1) | KR20070043985A (es) |
| AR (1) | AR049847A1 (es) |
| BR (1) | BRPI0513793A (es) |
| CR (1) | CR8876A (es) |
| EC (1) | ECSP077208A (es) |
| IL (1) | IL180846A0 (es) |
| MA (1) | MA28980B1 (es) |
| MX (1) | MX2007001188A (es) |
| NO (1) | NO20071107L (es) |
| PE (1) | PE20060382A1 (es) |
| RU (1) | RU2344134C2 (es) |
| TW (1) | TW200607493A (es) |
| UA (1) | UA88018C2 (es) |
| WO (1) | WO2006028590A1 (es) |
| ZA (1) | ZA200700477B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010225405B2 (en) * | 2009-03-18 | 2014-10-23 | Medicure International Inc. | Transdermal pharmaceutical preparation and administration of tirofiban |
| WO2013188254A1 (en) | 2012-06-11 | 2013-12-19 | Bristol-Myers Squibb Company | Phosphoramidic acid prodrugs of 5 - [5 - phenyl- 4 - (pyridin- 2 - ylmethylamino) quinazolin- 2 - yl] pyridine- 3 - sulfonamide |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2140865B2 (de) * | 1971-08-14 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | 1 -Imidazolyl-methanphosphonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
| DE19951701A1 (de) * | 1999-10-27 | 2001-05-03 | Aventis Pharma Gmbh | Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten |
| ATE400551T1 (de) * | 2002-01-04 | 2008-07-15 | Neurosearch As | Kaliumkanal-modulatoren |
-
2005
- 2005-07-19 AR ARP050102975A patent/AR049847A1/es unknown
- 2005-07-22 PE PE2005000858A patent/PE20060382A1/es not_active Application Discontinuation
- 2005-07-22 TW TW094125011A patent/TW200607493A/zh unknown
- 2005-07-25 BR BRPI0513793-4A patent/BRPI0513793A/pt not_active IP Right Cessation
- 2005-07-25 RU RU2007107408/04A patent/RU2344134C2/ru not_active IP Right Cessation
- 2005-07-25 KR KR1020077002228A patent/KR20070043985A/ko not_active Withdrawn
- 2005-07-25 WO PCT/US2005/026334 patent/WO2006028590A1/en not_active Ceased
- 2005-07-25 UA UAA200702125A patent/UA88018C2/ru unknown
- 2005-07-25 MX MX2007001188A patent/MX2007001188A/es unknown
-
2007
- 2007-01-16 ZA ZA200700477A patent/ZA200700477B/xx unknown
- 2007-01-21 IL IL180846A patent/IL180846A0/en unknown
- 2007-01-25 CR CR8876A patent/CR8876A/es not_active Application Discontinuation
- 2007-01-26 EC EC2007007208A patent/ECSP077208A/es unknown
- 2007-02-21 MA MA29689A patent/MA28980B1/fr unknown
- 2007-02-27 NO NO20071107A patent/NO20071107L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| UA88018C2 (ru) | 2009-09-10 |
| IL180846A0 (en) | 2007-06-03 |
| KR20070043985A (ko) | 2007-04-26 |
| MA28980B1 (fr) | 2007-11-01 |
| ZA200700477B (en) | 2009-08-26 |
| MX2007001188A (es) | 2007-03-21 |
| BRPI0513793A (pt) | 2008-05-13 |
| NO20071107L (no) | 2007-04-19 |
| CR8876A (es) | 2007-08-28 |
| RU2344134C2 (ru) | 2009-01-20 |
| ECSP077208A (es) | 2007-02-28 |
| WO2006028590A1 (en) | 2006-03-16 |
| TW200607493A (en) | 2006-03-01 |
| AR049847A1 (es) | 2006-09-06 |
| RU2007107408A (ru) | 2008-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR045595A1 (es) | Composiciones utiles como inhibidores de proteinas quinasas | |
| GT200500102A (es) | Compuestos de aril-o-heteroarilamida ortosustituidos | |
| TW200608969A (en) | Heterocyclic boronic acid compounds | |
| PE20071061A1 (es) | Derivados de carbonilo como inhibidores de peptidil-deformilasa (pdf) | |
| PE20070370A1 (es) | Compuestos derivados de carboxamidas como agentes fungicidas | |
| CY1112921T1 (el) | Ενεργοποιητες γλυκοκινασης πυρρολιδινονης | |
| PE20061436A1 (es) | Derivados de amida sustituida como inhibidores de proteina quinasa | |
| PE20060777A1 (es) | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas | |
| PE20091575A1 (es) | Derivados bifenilo como inhibidores del virus de la hepatitis c | |
| PE20140690A1 (es) | Benzoxazepinonas fusionadas como moduladoras de canales ionicos | |
| PE20090511A1 (es) | Imidazopiridinonas | |
| ATE435855T1 (de) | Verbindungen mit agonistischer wirkung am beta2- adrenergen rezeptor und am muscarinischen rezeptor | |
| AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
| EA200700099A1 (ru) | Производные пиридина | |
| TW200505920A (en) | Organic compounds | |
| PE20081850A1 (es) | Derivados ciclizados como inhibidores de la eg-5 | |
| CY1109962T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας | |
| EA201070804A1 (ru) | (аза)индольное производное, замещенное по положению 5, содержащая его фармацевтическая композиция, промежуточные соединения и способ их получения | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| ECSP088484A (es) | Derivados de quinazolina espirocíclicos como inhibidores de pde7 | |
| ATE487715T1 (de) | Triazolderivate als modulatoren von dopamin-d3- rezeptoren | |
| PE20060692A1 (es) | Inhibidores bace | |
| ES2368594T3 (es) | Derivados sustituidos de ciclohexilmetilo. | |
| PE20090712A1 (es) | Moduladores de la gamma secretasa | |
| EA200400086A1 (ru) | Новые производные оксазолидинонов в качестве антибактериальных агентов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |